Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now


  •   Email
  •   Print
  •   Share
  • Dana-Farber Blog

    • Insight Blog screenshot Insight features the latest in cancer care and research news from Dana-Farber.
    • Read the blog 
  • Dana-Farber Facts

    • cover of the Dana-Farber 2016 Facts brochureFind statistics on Dana-Farber's patient care, fundraising initiatives and achievements, and phone numbers for patients and families.
    • View Dana-Farber Facts
  • More than Courage

    • More than Courage coverLearn more about Dana-Farber and the Jimmy Fund's courageous care, innovation, and commitment to beating cancer.
    • View More than Courage
  • The Cancer Treatment Revolution

    • The Cancer Treatment Revolution book cover Dr. David Nathan, acclaimed pediatric hematologist and Dana-Farber's president from 1995 – 2000, recounts that history's triumphs and struggles in his book, The Cancer Treatment Revolution.

Dana-Farber Spotlight

Sign up to receive Dana-Farber Spotlight, our email newsletter.
View the current issue
Subscribe now
Unsubscribe from mailings

Media Contacts

Ellen Berlin
Director of Media Relations

Molly McHale
Associate Director of Media Relations


Top News Releases

Barrett Rollins, MD, PhD
Pasi A. Jänne, MD, PhD
Jennifer Ligibel, MD
  • October 11, 2016
  • Dana-Farber study testing the impact of weight loss on breast cancer recurrence
  • Researchers from Dana-Farber Cancer Institute and partnering oncology practices across the United States and Canada are testing whether weight loss prevents women with breast cancer from a recurrence. Nestlé Health Science is donating OPTIFAST® nutritionally complete, low calorie meal replacements to help women in the newly launched Breast Cancer Weight Loss (BWEL) study realize their weight loss goals.
Ursula Matulonis, MD

Dana Farber In the News


    Image Alt Text
    Image Alt Text
    Image Alt Text